Connect Biopharma Holdings Ltd
CNTB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001835268
No open-market purchases or sales by Connect Biopharma Holdings Ltd insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $33.1M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Connect Biopharma Holdings Ltd insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Connect Biopharma Holdings Ltd, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Xanthopoulos Kleanthis Gabriel | Director | 86,554 | Jul 1, 2026 | 2 |
| Liu Jean I | Director | 11,779 | Jul 1, 2026 | 2 |
| Huang James | Director | 13,310,000Indirect | Jun 2, 2026 | 2 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 (view filing) | May 29 | 4 days | Huang JamesDirector | PPurchase | +150.0K | $2.48 | +$372.0K | +1.1%13.3M after | |
| Apr 1, 2026 (view filing) | Mar 31 | 1 day | Huang JamesDirector | PPurchase | +1.16M | $3.45 | +$4.00M | +9.7%13.2M after |